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Evaluation of the Accuracy of Diagnostic Tests
From Repeated Measurements Without
a Gold Standard
Bas ENGEL, Jantien BACKER, and Willem BUIST
A model is presented to evaluate the accuracy of diagnostic tests from data from
individuals that are repeatedly tested in time. Repeated measurements from three di-
agnostic tests for foot-and-mouth disease, applied to vaccinated and experimentally
infected cattle, were analyzed. At any time the true disease status of the individuals was
unknown, i.e., no gold standard was available. The model allows for correlation be-
tween repeated test results, in consequence of the underlying structure for the unknown
true disease status, but also by the distribution of the test results conditional upon true
disease status. The model also allows for dependence between the different diagnostic
tests conditional upon true disease status. Prior information about the structure of the
prevalence and the specificity of the tests was incorporated in a Bayesian analysis. Pos-
terior inference was carried out with Markov chain Monte Carlo. Simulated data were
analyzed to gain insight into the performance of the posterior Bayesian inference. The
simulated data are typical for the expensive and, therefore, modestly sized infection
experiments that are conducted under controlled conditions.
Key Words: Bayesian analysis; Foot and mouth disease; Infection experiment; Latent
class model; Longitudinal data; MCMC; Sensitivity; Specificity.
1. INTRODUCTION
In an infection experiment, animals are experimentally infected and repeatedly tested
in time, under controlled conditions. This study was motivated by data from cattle that
were experimentally infected with the foot-and-mouth disease (FMD) virus. An animal was
considered to be truly positive when it had started to produce specific antibodies against the
FMD virus (seroconversion). However, the moment of seroconversion was unknown. All of
the diagnostic tests applied to sera of the animals were imperfect and no perfect reference
test was available. Consequently, at any time where animals were tested, their true disease
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status was unknown. The aim of this study was to evaluate the sensitivity (probability that a
truly positive animal tests positive) and specificity (probability that a truly negative animal
tests negative) of the diagnostic tests.
The majority of the literature on evaluation of diagnostic tests in the absence of a gold
standard involves tests that are applied once to each individual, e.g., Hui and Walter (1980),
Yang and Becker (1997), Qu, Tan, and Kutner (1996), Qu and Hadgu (1998), Dendukuri
and Joseph (2001), Georgiades et al. (2003), Engel et al. (2006) (and references therein).
When many individuals are repeatedly tested over a longer period and possibly some or all
are tested at different times, these repeated measurements need to be modeled in a biologi-
cally sensible and statistically parsimonious fashion. Cook, Ng, and Meade (2000) modeled
repeated diagnostic measurements with a latent Markov model and considered maximum
likelihood estimation. Miglioretti (2003), although in a different context, presented a re-
lated model, employing a Bayesian analysis. Here, the model for true disease status for
the FMD data is motivated by a simple mechanistic structure, employing a threshold con-
cept. The diagnostic tests in the FMD study are based on similar biological principles.
Therefore, conditional upon the true disease status (seropositive or not), the model allows
for dependence between the tests. In contrast to Cook, Ng, and Meade (2000), we allow
for dependence in time between repeated results of the same test, conditional upon true
disease status of the individual, as well. We performed a Bayesian analysis, incorporat-
ing prior information about the prevalence structure and the specificities of the diagnostic
tests, employing the Markov chain Monte Carlo algorithm (Gelman et al. 1995) that is im-
plemented in the WinBUGS program (Spiegelhalter et al. 2003). Properties of parameter
estimators (posterior medians) and 95% credible intervals (95CI) were investigated in a
simulation study.
The FMD data are introduced in Section 2 and models for this data are derived in Sec-
tion 3. Prior distributions are discussed in Section 4 and settings for the simulation study
are presented in Section 5. Results of the analyses of the FMD data and the simulated data
are presented in Section 6. Summarizing remarks about the analyses, possible extensions of
the model, and a brief discussion about choice of true state and conditional (in) dependence
between diagnostic tests are presented in Section 7.
2. THE FMD DATA
FMD is a contagious disease that occurs in cloven-hoofed cattle. Outbreaks can cause
high financial losses, with a considerable negative social impact (Kitching, Hutber, and
Thrusfield 2005). The test data that are analyzed in this article (Table 1) are from sera from
261 vaccinated cattle that were experimentally infected with the FMD virus. 75 of the
animals were tested at least twice. The data are part of a larger dataset that was collected
for a workshop in Brescia, Italy (Brocchi et al. 2006). Six diagnostic tests were performed
under the same conditions by the same laboratory in Italy. Engel et al. (2008) performed
a Bayesian analysis of the large dataset, which comprised field data as well, but only one
data point was used (that was nearest to 28 days post infection) per experimentally infected
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Table 1. Summary statistics of the FMD data.
Number of observations (on 3 diagnostic tests) per animal
Number of observations (time Number of










Total number of animals 261
Joint test results (summed over time points)
Number of times
Joint test results per time point Total ≤21 dpi >21 dpi
− − − 179 105 74
− − + 8 6 2
− + − 44 9 2
− + + 6 4 2
+ − − 12 6 6
+ − + 20 13 7
+ + − 20 2 18
+ + + 258 116 142
Total number of times 514 261 253
animal. Three tests clearly outperformed the other tests with respect to accuracy. In the
present study, attention was restricted to these three tests.
The tests are designed to detect specific antibodies against the FMD virus. They are
based on the principle that highly purified FMD vaccines contain purified inactivated FMD
capsids. The nonstructural proteins are absent or almost absent. Vaccination, therefore,
does not induce antibodies against the nonstructural proteins, whereas infection does. True
positive state was defined as seroconversion for nonstructural proteins, i.e., presence of
(specific) antibodies.
Times (days post infection, or dpi) where tests were performed, varied from 7 to 168 dpi
and the 25th, 50th, and 75th percentiles were 11, 21, and 56 dpi, respectively. Most joint
test results were all negative (35% of the time) or all positive (50% of the time).
3. THE MODEL
3.1. MODELING PREVALENCE
Once an animal has seroconverted, it will remain true positive, because antibodies re-
main in the blood during the experimental period. The moment of experimental infection
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is the natural origin for time t (dpi). A latent pressure h(t) is assumed that increases with
time, such that an individual becomes true positive when h(t) exceeds the individual’s
threshold u. Hence, prevalence p(t) = P(u ≤ h(t)) at time t . Cf. Engel et al. (2008), u is
assumed to follow a standard Logistic distribution:
logit(p(t)) = h(t) with h(t) = a + b(log(T ) − log(21)), b > 0, (3.1)
where T = t , when t ≤ 21, and T = 21, when t > 21. This reflects expert opinion that
seroconversion after 21 dpi is very unlikely. Prevalence starts with p(0) = 0 and increases
with time until a maximum P is reached at t = 21 dpi, where a = logit(P ).
An alternative three-parameter model can be motivated by a two-step process: an in-
dividual becomes seropositive with probability P , and then seroconverts when h(t) ≥ u.
With a similar choice for pressure h(t), but avoiding the nonsingularity at t = 21 dpi:
logit(p(t)/P ) = h(t) with h(t) = a + b(log(t) − log(21)), b > 0. (3.2)
Here, a = logit(p(21)/P ); the logit of the expected proportion of seropositives that
turns seropositive before 21 dpi. We will analyze data with Equations (3.1) and (3.2).
3.2. MODELING JOINT TEST RESULTS CONDITIONAL UPON TRUE DISEASE
STATUS
Initially, similar to e.g., Cook, Ng, and Meade (2000) and Schulzer, Anderson, and
Drance (1991), conditional upon true status D (0/1 for a true negative/positive) of the indi-
vidual, results of the same test were assumed to be independent in time. Joint test results
y1, y2, and y3 (0/1 for a negative/positive test) of the three tests at any time t were modeled
cf. Engel et al. (2006). For a true negative or true positive animal, respectively:










θ−ijk = −iδ−1 − jδ−2 − kδ−3 + ijε−12 + ikε−13 + jkε−23,
θ+ijk = (i − 1)δ+1 + (j − 1)δ+2 + (k − 1)δ+3 + (i − 1)(j − 1)ε+12
+ (i − 1)(k − 1)ε+13 + (j − 1)(k − 1)ε+23, i, j, k = 0,1.
Because all tests aim for detection of antibodies, while seroconversion is the true positive
state of interest, (conditional) probabilities for test results y are assumed to depend on
time through true disease status D only. “Main effects” δ− and δ+ are associated with
specificities and sensitivities and “interactions” ε− and ε+ are associated with dependence
between tests, conditional upon true disease status D = 0 or 1. For instance:
logit(P (y2 = 1|D = 1, y1 = i, y3 = k)) = δ+2 + (i − 1)ε+12 + (k − 1)ε+23. (3.4)
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So, δ+2 is the logit of the sensitivity of test 2, conditional upon the correct test results
y1 = y3 = 1 of the other tests. Interactions ε are log odds ratios, for instance:
ε+23 = log
(
P(y2 = 1|D = 1, y1 = i, y3 = 1)
P (y2 = 0|D = 1, y1 = i, y3 = 1)
/P(y2 = 1|D = 1, y1 = i, y3 = 0)




This is the logarithm of the cross product ratio of tests 2 and 3, conditional upon result
y1 = i of test 1. Because in Equation (3.3) attention is restricted to two-factor interac-
tions only, Equation (3.5) does not depend on y1. Conditional independence between tests
corresponds to interactions ε = 0. Positive interaction terms ε correspond to positive de-
pendence between tests, i.e., a tendency for concordant observations.
The sensitivity (α) and specificity (β) of a test can be derived from the conditional joint








3.3. MODELING SUBJECT SPECIFIC SENSITIVITY AND SPECIFICITY
To incorporate dependence between repeated measurements, conditional upon true dis-
ease status D, a notion of subject specific sensitivity and specificity was introduced by
adding normally distributed random animal effects ν to the main effects δ in the multino-
mial probabilities of Equation (3.3). Conditional upon D, there are two (potential) sources
of dependence between test results y: global correlation due to (unobserved) character-
istics of the individual that affect a test in a similar fashion at all times, associated with
the random ν effects, and local residual correlation between tests at each time, asso-
ciated with the interaction terms ε. Separate animal effects ν− = (ν−1, ν−2, ν−3)′ and
ν+ = (ν+1, ν+2, ν+3)′ were introduced for tests 1, 2, and 3, with common variances σ 20
and σ 21 for true negatives and true positives, respectively. Both independent and correlated
ν effects for tests within individuals, with common correlations ρ0 and ρ1 for true negatives
and positives, were considered. The model is graphically represented in Figure 1.
Marginal probabilities are obtained by integration over random effects ν. For modestly
sized variances σ 20 and σ
2
1 , this approximately involves shrinkage, e.g., the following ex-
pressions may be compared with Equations (3.4) and (3.5):
logit(P (y2 = 1|D = 1, y1 = i, y3 = k))




P(y2 = 1|D = 1, y1 = i, y3 = 1)
P (y2 = 0|D = 1, y1 = i, y3 = 1)
/P(y2 = 1|D = 1, y1 = i, y3 = 0)
P (y2 = 0|D = 1, y1 = i, y3 = 0)
)
≈ ξ1ε+23,
where ξ1 = 1/
√
1 + σ 21 /c2 and c = 1516π/
√
3 (see e.g. Engel, Buist, and Visscher 1995).
Equation (3.7) will not be used in the actual calculations, but will be useful to motivate
priors for main effects δ and interactions ε in Section 4.
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Figure 1. A graphical representation of the model.
3.4. CALCULATING MARGINAL SENSITIVITY AND SPECIFICITY
Let the subject specific sensitivity of a random individual, say for test 1, be α1(ν+),
where this sensitivity depends on the individual through its random effects ν+ =
(ν+1, ν+2, ν+3)′. The marginal sensitivity is: α1 = E(α1(ν+)) (and similarly the marginal
specificity is β1 = E(β1(ν−))). The average of the subject specific sensitivities α1(ν+) of
the individuals offers an approximation for α1 that can be simply included in the Markov
chain Monte Carlo (MCMC) process:
αˆsimple,1 = α1(ν+). (3.8)
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A more accurate, but computer intensive approximation can be derived by Gauss–Hermite









Here, by spectral decomposition, νijk =
√































xijk = (xi, xj , xk)′, abscissas xl and weights wl, l = −n, . . . , n, are derived from Hermite











θ+lmn(νijk) = (l − 1)(δ+1 + νijk,1) + (m − 1)(δ+2 + νijk,2) + (n − 1)(δ+3 + νijk,3)
+ (l − 1)(m − 1)ε+12 + (l − 1)(n − 1)ε+13 + (m − 1)(n − 1)ε+23,
l,m,n = 0,1.
Every fifth value of the δ’s, ε’s, σ 20 , σ
2
1 , ρ0, and ρ1 (but not the ν’s) was taken from the
Markov chain of length 50,000, after a burn in of 5,000. Each set of simulated parameter
values, αˆGH,i and βˆGH,i , i = 1,2,3, was evaluated by Equation (3.9) with n = 20 (n = 30
yielded the same results), providing samples of size 10,000 from the posteriors.
4. PRIOR DISTRIBUTIONS
Expert opinion was expressed about the time to seroconversion and about the maximum
prevalence, involving parameters a and P (Table 2). In Equation (3.1), when seroconver-
sion occurs, it will occur before 21 dpi and in Equation (3.2), more cautiously, largely
before 21 dpi. Engel et al. (2008; table 2, vaccinated animals of group G4), employing
Equation (3.1), used an informative prior for the maximum prevalence. However, the prior
and posterior were found to be markedly different. Therefore, in the present study diffuse
priors were used for a in Equation (3.1) and logit(P ) in Equation (3.2).
A diffuse prior from 0 to 21 dpi was specified for the median time m, where p(m) = P/2
(Table 2). The prior for coefficient b followed from b = (logit(P/2) − a)/(log(m) −
log(21)) for Equation (3.1), and b = −a/(log(m)− log(21)) for Equation (3.2). For Equa-
tion (3.1), the priors for a and m (Table 2) and the induced prior for b were used. For
Equation (3.2), to ensure that b was positive valued, the induced prior was approximated
by a lognormal distribution (Table 2) and used together with the prior for a.
Priors for σ0 and σ1 followed from consideration of log odds ratios between individuals
with random effects u and u′, e.g., from Equation (3.4):
logit(P (y1 = 1|D = 1, y2 = y3 = 1,ν = u))
− logit(P (y1 = 1|D = 1, y2 = y3 = 1,ν = u′)) = u1 − u′1.
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Table 2. Prior distributions for the FMD data and for the simulated data. In the simulation P = 0.9 or 0.4. From
left to right, for the FMD data and the simulated data, the 5th/50th/95th percentiles of the priors for P
are 0.09/0.50/0.91, 0.80/0.90/0.95, and 0.31/0.40/0.50. The 5th/50th/95th percentiles of the prior of m
are 1.2/10.5/19.7.
Simulated data
Parameter FMD data True P = 0.9 True P = 0.4
a Eq. (3.1) N(0,0.5)(1) N(2.1654,4.4584) N(−0.4055,16.46)
Eq. (3.2) N(2.1654,4.4584) N(2.1654,4.4584) N(2.1654,4.4584)
m Eq. (3.1) 21 ∗ Beta(1.1,1.1) 21 ∗ Beta(1.1,1.1) 21 ∗ Beta(1.1,1.1)
logit(P ) Eq. (3.2) N(0,0.5) N(2.1654,4.4584) N(−0.4055,16.46)
b Eq. (3.1) Induced by a and m Induced by a and m Induced by a and m
Eq. (3.2) Lognormal(1.3,0.67)(2) Lognormal(1.3,0.67) Lognormal(1.3,0.67)
δ−1 N(2.85,1.13) N(2.85,1.13) N(2.85,1.13)
δ−2 N(2.85,1.13) N(2.85,1.13) N(2.85,1.13)
δ−3 N(2.85,1.13) N(2.85,1.13) N(2.85,1.13)
δ+1 N(0,0.5) N(0,0.5) N(0,0.5)
δ+2 N(0,0.5) N(0,0.5) N(0,0.5)
δ+3 N(0,0.5) N(0,0.5) N(0,0.5)
all ε Gamma(0.48,1)(3) Gamma(0.48,1) Gamma(0.48,1)
σ0, σ1 Uniform(0,0.77) – –
ρ0, ρ1 Uniform(0,1) – –
(1)N(μ, τ) is a Normal distribution with mean μ and precision τ (variance 1/τ ).
(2)Lognormal(μ, τ) is N(μ, τ) after log transformation.
(3)Gamma(a, b) is a Gamma distribution with mean a/b and variance a/b2.
Choosing ±log(6) for the fifth and 95th percentiles ±1.645√2σ1, an upper bound for a
Uniform prior (Gelman 2006) for σ1 (and σ0) of 0.77 was obtained. Because shrinkage
factors, such as ξ1 in Equation (3.7), will be larger than 0.91, priors for main effects δ
(Table 2) were chosen cf. Engel et al. (2006, 2008): diffuse priors for effects δ+ and more
informative priors for effects δ− (because producers of tests aim for high specificity). Dif-
fuse priors were used for interactions ε and correlations ρ (Table 2).
5. SIMULATION
Data were simulated with Mathematica (Wolfram Research, Inc. 2007) and analyzed
with WinBUGS (Spiegelhalter et al. 2003). Data were mainly simulated for the prevalence
structure in Equation (3.2), for three diagnostic tests, for 20 individuals with 10 times
per individual (4,6, . . . ,22 dpi), for 10 individuals with 20 time points (3,4, . . . ,22 dpi)
and for 10 individuals with 10 time points (4,6, . . . ,22 dpi) (Table 3). Subject specific
ν effects were not included in the simulation. In the simulation, test 3 was independent
of tests 1 and 2, but in the analysis possible dependence between all tests was assumed.
Values P = 0.4 and 0.9 were considered typical for maximum prevalence for vaccinated
and nonvaccinated animals, respectively. Relatively high (0.95, 0.75, 0.85) and modest to
low (0.70, 0.40, 0.60) sensitivities were considered. Specificities were chosen equal to 0.97.
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Table 3. Parameter values in the simulation.
Parameter Value
P maximum prevalence 0.9 0.9 0.4
a = logit(p(21)/P ) 2.197 2.197 2.197
m time (dpi) where prevalence is P/2 10 10 10
b 2.962 2.962 2.962
α1 sensitivity of test 1 0.95 0.70 0.70
α2 sensitivity of test 2 0.75 0.40 0.40
α3 sensitivity of test 3 0.85 0.60 0.60
β1, β2, and β3 specificity of tests 1, 2, and 3 0.97 0.97 0.97
δ+1 = logit(P (y1 = 1|D = 1, y2 = 1)) 3.540 1.865 1.865
δ+2 = logit(P (y2 = 1|D = 1, y1 = 1)) 1.193 −0.0207 −0.0207
δ+3 = logit(α3) 1.735 0.405 0.405
δ−1 = logit(P (y1 = 0|D = 0, y2 = 0)) 3.505 3.505 3.505
δ−2 = logit(P (y2 = 0|D = 0, y1 = 0)) 3.505 3.505 3.505
δ−3 = logit(β3) 3.476 3.476 3.476
ε+12 = log( P (y1=1,y2=1|D=1)P (y1=0,y2=0|D=1)P (y1=0,y2=1|D=1)P (y1=1,y2=0|D=1) ) 1.504 = log(4.5) 1.504 1.504
ε−12 = log( P (y1=1,y2=1|D=0)P (y1=0,y2=0|D=0)P (y1=0,y2=1|D=0)P (y1=1,y2=0|D=0) ) 0.693 = log(2) 0.693 0.693
ε−13, ε+13, ε−23, ε+23 0 0 0
Simulation results presented in Table: 5(a) 5(b) 5(c), 6(a), 6(b)
6. RESULTS
The FMD data were analyzed with prevalence structures using Equations (3.1) and
(3.2). Models fitted to the data comprised different choices for σ 20 , σ 21 , ρ0, and ρ1 for the
random effects ν, a model without interaction terms ε and a model ignoring the repeated
measurements (as if the data were from as many individuals as there were time points).
Chains of length 50,000, after a burn in of 5,000, on average required some eight hours
computing time on a desktop computer with Intel Xeon processors, 3.60 GHz CPU and
3Gb RAM.
In the simulation study, simulations were initially run with prevalence structures using
Equations (3.1) and (3.2), with similar results. Results after 50,000 and 100,000 MCMC
iterations were basically the same. Subsequently, more extensive simulations were per-
formed with Equation (3.2), employing chains of length 50,000, after a burn in of 5,000.
Results of these simulations will be presented below. Although the simulated datasets were
smaller and more regular than the FMD data, computing time was still substantial: 55,000
iterations required some 25 minutes or, occasionally, several hours. Some 2%–5% of the
simulations terminated with an error message from WinBUGS. In an analysis of real data
this is often resolved by a judicious choice of starting values. In the simulation study, sim-
ulations with error messages were discarded. Label switching (Redner and Walker 1984)
produces parameter values with the same likelihood (but lower prior probability). The al-
gorithm may get “stuck” in the neighborhood of such a “mirror image” (see also Engel
et al. 2006), yielding unacceptably low specificities (and sensitivities) after 55,000 iter-
ations. Simulations that did not comply with the condition α + β > 1 for all tests were
92 B. ENGEL, J. BACKER, AND W. BUIST
marked as potential cases of label switching and discarded. This occurred infrequently, ex-
cept when prevalence and sensitivities were relatively low (Table 5(c)) and some 3% of the
simulations had to be discarded.
6.1. RESULTS FOR THE FMD DATA
Results from the Gauss–Hermite integration of Equation (3.9) are reported in Table 4.
Similar results were found with the simple average of Equation (3.8). Results for various
models fitted to the data, employing the prevalence structure found in Equation (3.1) (Ta-
ble 4(a)), were similar, except for the model without interaction (ε = 0) and the model
where the repeated measurements structure was ignored. Random effects ν for additional
dependence, conditional upon true disease status, had no apparent effect on the results.
Only when interactions ε were assumed to be 0, was the correlation ρ1 noticeably in-
creased, thus also accounting for conditional dependence between tests for true positives.
With Equation (3.2) (Table 4(b)), for some of the models considered, starting values
had to be chosen with care, to avoid label switching. Although results using the preva-
lence structures of Equations (3.1) and (3.2) were similar (considering the width of the
associated 95CI), sensitivities were noticeably higher for Equation (3.2). Omission of in-
teraction terms ε for Equation (3.2) had a less pronounced effect on correlation ρ1 than
for Equation (3.1). When the repeated measurement structure was ignored, practically the
same results were found for Equation (3.2) as before. This is consistent with the simulation
results in Section 6.2.
We could argue that in Equation (3.2), if we have high confidence in expert opinion, the
prior for a should have been focused on higher values, in order to make prior information
for Equations (3.1) and (3.2) more comparable. However, a N(3.4,2.67) distribution for a
that focuses on higher values for p(21)/P around 0.95, produced nearly the same results
as in Table 4(b).
Inspection of the sum of the test results, per individual and per time of measurement,
suggested that 7 individuals might have seroconverted after 21 dpi. Without these individ-
uals, estimated sensitivities (and specificities) with Equations (3.1) and (3.2) (not shown)
were quite similar. When the repeated measurement structure is ignored, it will no longer
be apparent that after 21 dpi some animals have three negative test results followed by
three positive test results. Indeed, in the latter instance, results under Equation (3.1) or
Equation (3.2), as reported in the last column of Table 4, were practically the same (and
similar to the results obtained without the 7 suspect individuals). When times t > 21 were
replaced by 21 dpi in the analysis with Equation (3.2), effectively bringing the “offending”
observations of the 7 animals forward in time, prevalence at 21 dpi was increased, sensi-
tivity was decreased and specificity was increased, and results were virtually identical to
the results with Equation (3.1). When time t was truncated at 28 dpi, results with Equa-
tion (3.2) hardly changed from the results without truncation as reported in Table 4(b).
Apparently, the greater flexibility of Equation (3.2) has some impact on the results in
connection with the 7 animals that possibly did not seroconvert before 21 days. It is hard
to discriminate between Equations (3.1) and (3.2) in terms of goodness of fit. Considering
the width of the credible intervals, the differences between Equations (3.1) and (3.2) are
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Table 4. Results of analyses of the FMD data. Estimates (posterior medians) and 95% credible intervals (in
parentheses) for different models. The full model comprises the threshold concept and ν effects.
Full model,
but:













(a) Results with prevalence structure (1)
α1 0.93 0.92 0.93 0.95 0.96
(0.88, 0.96) (0.88, 0.96) (0.89, 0.96) (0.92, 0.97) (0.93, 0.98)
α2 0.87 0.87 0.87 0.89 0.91
(0.82, 0.91) (0.81, 0.91) (0.83, 0.91) (0.85, 0.92) (0.87, 0.94)
α3 0.87 0.87 0.86 0.90 0.91
(0.82, 0.91) (0.82, 0.91) (0.82, 0.90) (0.86, 0.93) (0.87, 0.94)
β1 0.98 0.98 0.97 0.97 0.95
(0.94, 0.99) (0.94, 0.99) (0.94, 0.99) (0.94, 0.99) (0.91, 0.99)
β2 0.96 0.96 0.96 0.95 0.95
(0.91, 0.98) (0.92, 0.98) (0.92, 0.98) (0.91, 0.98) (0.91, 0.98)
β3 0.96 0.96 0.96 0.96 0.96
(0.92, 0.99) (0.91, 0.99) (0.92, 0.98) (0.92, 0.98) (0.92, 0.98)
P 0.74 0.75 0.74 0.73 0.64
(0.67, 0.80) (0.68, 0.82) (0.64, 0.79) (0.67, 0.79) (0.59, 0.69)
σ 20 0.20 0.17 – 0.29 –
(0.00, 0.57) (0.00, 0.56) (0.01, 0.58)
σ 21 0.54 0.54 – 0.56 –
(0.34, 0.59) (0.35, 0.59) (0.42, 0.59)
ρ0 0.47 – – 0.52 –
(0.02, 0.94) (0.04, 0.98)
ρ1 0.45 – – 0.85 –
(0.03, 0.94) (0.49, 0.99)
(b) Results with prevalence structure (2)
α1 0.96 0.96 0.97 0.97 0.96
(0.93, 0.98) (0.92, 0.98) (0.94, 0.99) (0.94, 0.99) (0.93, 0.98)
α2 0.91 0.90 0.92 0.91 0.92
(0.87, 0.95) (0.86, 0.94) (0.88, 0.95) (0.87, 0.94) (0.87, 0.95)
α3 0.91 0.90 0.91 0.92 0.92
(0.87, 0.94) (0.86, 0.94) (0.87, 0.94) (0.88, 0.95) (0.87, 0.95)
β1 0.96 0.96 0.95 0.95 0.95
(0.90, 0.98) (0.92, 0.99) (0.91, 0.98) (0.91, 0.98) (0.91, 0.98)
β2 0.95 0.95 0.95 0.95 0.95
(0.90, 0.98) (0.91, 0.98) (0.91, 0.98) (0.90, 0.97) (0.91, 0.98)
β3 0.95 0.95 0.95 0.95 0.96
(0.89, 0.98) (0.91, 0.98) (0.91, 0.98) (0.92, 0.98) (0.92, 0.98)
P 0.79 0.77 0.77 0.78 0.69
(0.70, 0.90) (0.69, 0.86) (0.70, 0.85) (0.69, 0.86) (0.62, 0.78)
σ 20 0.30 0.25 – 0.33 –
(0.01, 0.58) (0.01, 0.58) (0.01, 0.58)
σ 21 0.54 0.54 – 0.54 –
(0.36, 0.59) (0.33, 0.59) (0.37, 0.59)
ρ0 0.60 – – 0.55 –
(0.06, 0.98) (0.01, 0.95)
ρ1 0.51 – – 0.69 –
(0.04, 0.94) (0.13, 0.95)
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not marked. However, the difference between e.g., 0.97 and 0.93 for sensitivity is practi-
cally important and estimated sensitivities tend to get more emphasis than their associated
credible intervals. We tend to favor Equation (3.2), because it allows for greater flexibility
in incorporating prior information about the prevalence structure.
6.2. RESULTS FOR THE SIMULATED DATA
All results are for the prevalence structure found in Equation (3.2) and with specificity
β1 = β2 = β3 = 0.97.
High Prevalence and High Sensitivity (P = 0.9, α1 = 0.95, α2 = 0.75, α3 = 0.85)
In the left-hand side of Table 5(a) results are shown for the repeated measurements
model employing the threshold concept. Clearly, the posterior medians as estimates for
sensitivity, specificity, and maximum prevalence are performing well: bias and root mean
squared error (RMSE) are small. The coverage probability and average width of the 95CI
Table 5. Results of analyses of simulated data with prevalence structure of Equation (3.2). 20 animals with
10 time points each (4,6, . . . ,22 dpi). Bias (% bias), width of 95% credible interval (% CI) and root
mean squared error (% RMSE), as a percentage of the true parameter value, and percentage coverage
probability (% CP) of the 95% credible interval. Results with the repeated measurements structure for
prevalence (by the threshold concept) and results ignoring the repeated measurements structure.
With repeated measurements structure Ignoring repeated measurements
Parameter True value % bias % CI % CP % RMSE % bias % CI % CP % RMSE
(a) Relatively high prevalence and high sensitivity (1225 simulated datasets)
α1 0.95 −1.3 10 94 3 −0.8 11 94 2
α2 0.75 −0.5 22 96 6 −0.3 24 96 6
α3 0.85 −0.8 16 95 4 −1.1 18 95 4
β1 0.97 −0.6 7 97 2 −0.8 9 97 2
β2 0.97 −0.5 7 98 2 −0.5 8 98 2
β3 0.97 −0.6 7 98 2 −1.3 9 98 2
a 2.197 −0.7 70 100 10 0.5 63 97 15
b 2.962 2.6 71 97 16 4.0 62 93 17
P 0.90 −0.3 18 100 17 −0.3 16 100 3
(b) Relatively high prevalence and moderate to low sensitivity (1294 simulated datasets)
α1 0.70 −0.4 27 97 6 1.3 37 96 9
α2 0.40 0.2 48 95 12 3.0 57 95 15
α3 0.60 −0.3 32 96 8 −0.8 39 96 9
a 2.197 −0.6 72 100 9 −0.7 72 100 11
b 2.962 3.4 74 100 17 8.0 80 95 20
P 0.90 −0.2 18 100 2 −0.4 18 100 2
(c) Relatively low prevalence and moderate to low sensitivity (1410 simulated datasets)
α1 0.70 −2.0 40 95 11 2.1 61 96 16
α2 0.40 0.0 71 95 19 8.4 98 94 25
α3 0.60 −1.7 48 95 13 −5.4 67 96 17
a 2.197 −1.0 80 100 6 −2.6 81 95 6
b 2.962 6.1 113 96 32 15.9 157 91 48
P 0.40 0.4 52 100 5 −1.6 50 100 7
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are satisfactory, except for the intervals for parameters a (or equivalently p/P ) and P , that
were too conservative.
Results for the interaction terms ε (not shown) were poor. For instance, for tests 1 and 2,
for true positives, bias and RMSE of ε+12, expressed as percentages of the true parameter
value, were −73.9% and 76.5%, respectively, and the coverage probability of the 95CI was
only 58%. Because these experiments are quite expensive, they are modestly sized and ap-
parently offer little information about conditional dependence between tests. In particular
it was hardly possible to establish that test 3 is independent of tests 1 and 2. The large
negative bias for the interaction terms is probably a consequence of the prior gamma dis-
tribution that favors small values. Another prior might possibly produce smaller bias, but
RMSEs would still be poor.
In the right-hand side of Table 5(a), results are shown for the same datasets, but now
the repeated measurements structure was completely ignored in the analysis. Results are
similar to the left-hand side of the table. For this parameter configuration, there was little
gain in accounting for the repeated measurements structure of the data.
Because similar results for specificity were found for the other parameter configurations,
in the following we will focus on sensitivity.
High Prevalence and Modest Sensitivity (P = 0.9, α1 = 0.70, α2 = 0.40, α3 = 0.60)
Posterior medians in Table 5(b) are practically unbiased. RMSEs are somewhat in-
creased and 95CI are wider, but still quite acceptable. Although lower sensitivities offer
more opportunity for detection of dependence between tests for true positives, results for
interaction terms (not shown) were still poor: for ε+12 percentage bias and RMSE were
−33.9% and 45.5%, respectively and the 95CI showed 83% coverage. Again results in the
left- and right-hand sides of the table are quite similar, although 95CI from the analysis
ignoring the repeated measurements are perceptibly wider.
Modest Prevalence and Modest Sensitivity (P = 0.4, α1 = 0.70, α2 = 0.40, α3 = 0.60)
Posterior medians in Table 5(c) are still practically unbiased. The average width of
the 95CI has markedly increased, but generally coverage probabilities are acceptable. The
RMSE has increased, but estimated values (posterior medians) will e.g., still show that
test 3 has poor sensitivity. There is a marked difference with the analysis ignoring the
repeated measurements, the latter showing distinctly wider 95CI and higher RMSE.
For interaction ε+12, bias, RMSE and coverage of the 95CI were −57.2%, 63.4%, and
76%, respectively.
For each parameter with true value θ and estimates θˆ and θˆ ′ with and without the
repeated measurements structure, differences (θˆ − θ)2 − (θˆ ′ − θ)2 were analyzed with
Wilcoxon’s signed rank test. All RMSEs for the corresponding parameters on the left- and
right-hand sides of Table 5(c) were significantly (P < 0.05) different, except for speci-
ficity β2. This was also true for Table 5(b), although differences were less marked. Even in
Table 5(a) differences were mostly significant, albeit of little importance.
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In the simulation, test 3 was conditionally independent of tests 1 and 2, but data were
analyzed assuming possible conditional dependence between all tests. Suppose that, in
practice, test 3 relates to a different biological principle than tests 1 and 2. We might as-
sume that all interactions with test 3 are negligible. The simulated data of Table 5(c) were
reanalyzed with ε−13 = ε−23 = ε+13 = ε+23 = 0. Although computing time was reduced
by some 50% and hardly any simulations had to be discarded, results (not shown) were
similar to the results in Table 5(c). So, the extra information about test 3 did not result in
any appreciable gain in accuracy of estimated sensitivities (or specificities).
Additional Simulations With Varying Numbers of Animals and Times per Animal
Table 6 offers a modest (because of the excessive computer time) impression of the
effects of varying numbers of animals and time points per animal. For 10 animals with
20 time points each (Table 6(a)), RMSE is higher than in Table 5(c) for 20 individuals
with 10 time points each. Results on the right-hand side of Table 6(a), where the repeated
measurement structure is ignored, are relatively poorer than results in the right-hand side
of Table 5(c). This confirms that for this configuration it is worthwhile to properly account
for the repeated measurements (at the least in the structure for true disease status).
Comparing results with 10 animals with 10 times each (Table 6(b)), with 10 animals and
20 times each (Table 6(a)), and 20 animals and 10 times each (Table 5(c)), we conclude
that employing more animals is more profitable than testing on more time points. With the
exception of sensitivity α2, results in Table 6(a) and 6(b), particularly for parameters a, b,
and P , are not markedly different. When the main interest is in studying the development
Table 6. More results of analyses of simulated data with prevalence structure in Equation (3.2) and varying
numbers of time points and numbers of animals.
With repeated measurements structure Ignoring repeated measurements
Parameter True value % bias % CI % CP % RMSE % bias % CI % CP % RMSE
(a) Relatively low prevalence and moderate to low sensitivity (977 simulated datasets)
10 animals with 20 time points each (3,4, . . . ,22 dpi)
α1 0.70 −2.8 41 94 14 −1.2 62 90 23
α2 0.40 −0.7 74 96 20 5.3 98 92 29
α3 0.60 −1.8 50 95 15 −8.1 68 93 23
a 2.197 −0.9 81 100 5 −0.5 81 100 8
b 2.962 12.4 166 96 48 26.5 208 86 67
P 0.40 0.5 54 95 4 0.8 50 98 10
(b) Relatively low prevalence and moderate to low sensitivity (957 simulated datasets)
10 animals with 10 time points each (4,6, . . . ,22 dpi)
α1 0.70 −5.0 55 96 16 −2.8 75 96 22
α2 0.40 0.7 97 96 26 7.6 127 94 34
α3 0.60 −3.3 66 96 18 −8.2 87 95 25
a 2.197 −0.7 82 100 4 −1.5 82 100 5
b 2.962 11.1 176 95 48 27.0 293 95 67
P 0.40 0.6 54 95 4 −0.2 53 100 7
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of the disease in time, there is hardly any gain in efficiency when a grid of more densely
spaced time points is used.
7. DISCUSSION
The model in this article, with the prevalence structure found in Equations (3.1) or (3.2),
can be used for analysis of test data from infection experiments with a disease with an
irreversible true positive status. We have shown in a simulation study that even for the
expensive, and, therefore, modestly sized, infection experiments that are conducted under
controlled conditions, proper modeling of the repeated measurements is worthwhile for
moderate prevalence and modest sensitivity.
When animals may recover, pressure h(t) may be modified to include e.g., a quadratic
time component. Intermittent behavior, e.g., in shedding virus when swabs of saliva or fe-
ces are collected for testing, may be modeled by adding a residual term e to threshold u
at each time point. In that case it would be expedient to use (independent) normal distrib-
utions for u and e, with an associated probit link function. When some animals may turn
seropositive after considerable time, an asymmetric link function, like the complemen-
tary log–log link function (associated with the extreme value distribution), may be more
appropriate. The distribution of u implicitly defines a distribution for the moment of sero-
conversion. The latter distribution can also be specified directly, maybe motivated by some
likely hazard function.
The prevalence structure may be generated by a latent Markov model, as discussed by
Cook, Ng, and Meade (2000). The time dependent transition probabilities, from times t ′
to t , from D = 1 to 0, and from D = 0 to 1 are 0 and P(h(t ′) < u ≤ h(t))/P (u > h(t ′)),
respectively. For known true status D, it would be natural to consider possible dependence
between repeated measurements, see e.g., Hedeker (2003). There is no obvious reason,
when true disease status is unknown, to ignore this dependence. Therefore, the random ν
effects, associated with subject specific sensitivity and specificity, were introduced in the
model. For the FMD data there was no indication that the extra conditional dependence was
of any marked importance. This may at least partly be due to the high values of sensitivity
(and specificity) that offer little opportunity to detect additional dependence in time on
top of the (trivial) dependence in time that follows from the unknown true state. In the
simulation, ν effects had to be omitted, to reduce computing time, which was still quite
substantial.
Simulated data were also analyzed assuming that test 3 was conditionally independent
of tests 1 and 2. This assumption may not be valid, because even when tests relate to
different biological principles (Gardner et al. 2000), conditional dependence may occur
when animals may be in varying stages of a disease. The highly structured prevalence for
repeated test results mitigates potential problems with identifiability of parameters that is
often associated with latent class models for diagnostic data. Here, there was no apparent
gain in accuracy of sensitivity and specificity of the tests when the independence of test 3
was imposed upon the model, although in theory identifiability should be considerably
enhanced by conditional independence.
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Sera with known true status, such as true negative sera from animals from a well pro-
tected and carefully monitored environment, were not included in the present analysis.
However, extension of the analysis with known true negatives (or positives) is straightfor-
ward. Data with known true status increase the possibility to study and motivate possible
conditional correlation between repeated test results.
The present model could be the basis for an analysis of sera obtained from repeated
visits to farms during an outbreak. Test results may have been obtained much later from the
stored serum samples. Suppose that a farm entered surveillance when it was located within
a certain radius of another farm that was confirmed positive. Possibly, at that moment, the
farm was already positive itself. Suppose that the date of collection of a sample and the
associated farm are known. Also assume that true state of farms was eventually known,
based on reliable end screening. For farms that were confirmed positive, there is no gold
standard, because generally the moment the disease was introduced at a farm is not known.
The moment of introduction can be included as an extra unknown parameter, with a prior
based on expert opinion, possibly utilizing additional information from data collected when
herds were culled, see Engel et al. (2005) for an example with Classical Swine Fever. In
principle, information about possible transmission of the disease between farms could be
included as well, although this would complicate the analysis considerably. Accounting
for the selective way farms enter into the dataset would be one of the problems. Excessive
computer time is likely to be another.
Generally, the choice of true positive state is a difficult issue in latent class models for
diagnostic data. For example, when some tests aim for detection of antibodies, such as
ELISA tests, and others for detection of genetic material, such as PCR tests, the mixture
that dominates the data may not necessarily correspond to the preferred true positive state
that is practically relevant. For instance, during an outbreak, the true state of interest would
be infectiousness of an animal. In that case, credible intervals may cover sensitivities and
specificities corresponding to several possible mixtures, such as seroconversion or not,
and absence or presence of genetic material (including that of dead virus or bacteria).
When posteriors are not multimodal, the posterior median, as an estimator, is a compromise
between these mixtures. Unless additional structure can be added to the model, based on
information about the relation between different potential mixtures, this fundamental bias
with respect to a preferred true positive state may remain whatever the size of the dataset.
For the FMD data, with regard to export, first and foremost was detection of animals that
had been in contact with the virus and seroconversion was an obvious choice for true state
in this respect. This was also the natural choice regarding the background of the tests, since
all were ELISA tests that aimed for detection of antibodies.
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